Guanhong Miao

Dr. Guanhong Miao

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2023 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
GMGuanhong Miao
Guanhong Miao
JDJason Deen
Jason Deen
JSJoseph B. Struzeski
Joseph B. Struzeski
MCMingjing Chen
Mingjing Chen
YZYing Zhang
Ying Zhang
JZJinying Zhao
Jinying Zhao

22 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JZJinying Zhao
Jinying Zhao
TGTongjun Gu
Tongjun Gu
CGCheng Gao
Cheng Gao
GMGuanhong Miao
Guanhong Miao
HPHelena Palma-Gudiel
Helena Palma-Gudiel
DBDavid A. Bennett
David A. Bennett
5-hydroxymethylcytosine, also known as the sixth DNA base of the genome, plays an important role in brain aging and neurological disorders such as Alzheimer’s disease. However, little is known about its genome-wide distribution and its association with Alzheimer’s disease pathology. Here, we report a genome-wide profiling of 5-hydroxymethylcytosine in 1079 autopsied brains (dorsolateral prefrontal cortex) of older individuals and assess its association with multiple measures of Alzheimer’s disease pathologies, including pathological diagnosis of Alzheimer’s disease, amyloid-β load, and PHFtau tangle density. Of 197,765 5-hydroxymethylcytosine regions detected, we identified 2821 differentially hydroxymethylated regions associated with Alzheimer’s disease neuropathology after controlling for multiple testing and covariates. Many differentially hydroxymethylated regions are located within known Alzheimer’s disease loci, such as RIN3, PLCG2, ITGA2B, and USP6NL. Integrative multi-omics analyses support a potential mechanistic role of 5-hydroxymethylcytosine alterations in Alzheimer’s disease. Our study presents a large-scale genome-wide atlas of 5-hydroxymethylcytosine in Alzheimer’s brain and offers insight into the mechanism underlying Alzheimer’s disease pathogenesis.

6 February 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
GMGuanhong Miao
Guanhong Miao
RPRaimund Pechlaner
Raimund Pechlaner
Oliver FiehnOliver Fiehn
Oliver Fiehn
KMKimberly M. Malloy
Kimberly M. Malloy
YZYing Zhang
Ying Zhang
JZJinying Zhao
Jinying Zhao
Background: Dyslipidemia is an independent risk factor for coronary heart disease (CHD). Standard lipid panel cannot capture the complexity of the blood lipidome (ie, all molecular lipids in the blood). To date, very few large‐scale epidemiological studies have assessed the full spectrum of the blood lipidome on risk of CHD, especially in a longitudinal setting. Methods and Results: Using an untargeted liquid chromatography–mass spectrometry, we repeatedly measured 1542 lipid species from 1835 unique American Indian participants who attended 2 clinical visits (≈5.5 years apart) and followed up to 17.8 years in the Strong Heart Family Study (SHFS). We first identified baseline lipid species associated with risk of CHD, followed by replication in a European population. The model adjusted for age, sex, body mass index, smoking, hypertension, diabetes, low‐density lipoprotein cholesterol, estimated glomerular filtration rate, education, and physical activity at baseline. We then examined the longitudinal association between changes in lipid species and changes in cardiovascular risk factors during follow‐up. Multiple testing was controlled by the false discovery rate. We found that baseline levels of multiple lipid species (eg, phosphatidylcholines, phosphatidylethanolamines, and ceramides) were associated with the risk of CHD and improved the prediction accuracy over conventional risk factors in American Indian people. Some identified lipids in American Indian people were replicated in European people. Longitudinal changes in multiple lipid species (eg, acylcarnitines, phosphatidylcholines, and triacylglycerols) were associated with changes in cardiovascular risk factors. Conclusions: Baseline plasma lipids and their longitudinal changes over time are associated with risk of CHD. These findings provide novel insights into the role of dyslipidemia in CHD.

1 August 2023 in Hypertension
Verified
Journal Article
Closed access
MCMingjing Chen
Mingjing Chen
GMGuanhong Miao
Guanhong Miao
YZYing Zhang
Ying Zhang
JUJason Gari Umans
Jason Gari Umans
ELElisa T. Lee
Elisa T. Lee
JZJinying Zhao
Jinying Zhao
BACKGROUND: Dyslipidemia is an important risk factor for hypertension and cardiovascular disease. Standard lipid panel cannot reflect the complexity of blood lipidome. The associations of individual lipid species with hypertension remain to be determined in large-scale epidemiological studies, especially in a longitudinal setting. METHODS: Using liquid chromatography-mass spectrometry, we repeatedly measured 1542 lipid species in 3699 fasting plasma samples at 2 visits (1905 at baseline, 1794 at follow-up, ~5.5 years apart) from 1905 unique American Indians in the Strong Heart Family Study. We first identified baseline lipids associated with prevalent and incident hypertension, followed by replication of top hits in Europeans. We then conducted repeated measurement analysis to examine the associations of changes in lipid species with changes in systolic blood pressure, diastolic blood pressure, and mean arterial pressure. Network analysis was performed to identify lipid networks associated with the risk of hypertension. RESULTS: Baseline levels of multiple lipid species, for example, glycerophospholipids, cholesterol esters, sphingomyelins, glycerolipids, and fatty acids, were significantly associated with both prevalent and incident hypertension in American Indians. Some lipids were confirmed in Europeans. Longitudinal changes in multiple lipid species, for example, acylcarnitines, phosphatidylcholines, fatty acids, and triacylglycerols, were significantly associated with changes in blood pressure measurements. Network analysis identified distinct lipidomic patterns associated with the risk of hypertension. CONCLUSIONS: Baseline plasma lipid species and their longitudinal changes are significantly associated with hypertension development in American Indians. Our findings shed light on the role of dyslipidemia in hypertension and may offer potential opportunities for risk stratification and early prediction of hypertension.

17 May 2024 in IEEE Transactions on Information Forensics and Security
Verified
Journal Article
Closed access
GMGuanhong Miao
Guanhong Miao
SWSamuel S. Wu
Samuel S. Wu
Conducting secure computations to protect against malicious adversaries is an emerging field of research. Current models designed for malicious security typically necessitate the involvement of two or more servers in an honest-majority setting. Among privacy-preserving data mining techniques, significant attention has been focused on the classification problem. Logistic regression emerges as a well-established classification model, renowned for its impressive performance. We introduce a novel matrix encryption method to build a maliciously secure logistic model. Our scheme involves only a single semi-honest server and is resilient to malicious data providers that may deviate arbitrarily from the scheme. The d-transformation ensures that our scheme achieves indistinguishability (i.e., no adversary can determine, in polynomial time, which of the plaintexts corresponds to a given ciphertext in a chosen-plaintext attack). Malicious activities of data providers can be detected in the verification stage. A lossy compression method is implemented to minimize communication costs while preserving negligible degradation in accuracy. Experiments illustrate that our scheme is highly efficient to analyze large-scale datasets and achieves accuracy similar to non-private models. The proposed scheme outperforms other maliciously secure frameworks in terms of computation and communication costs.

23 December 2023 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
GMGuanhong Miao
Guanhong Miao
LYLei Yu
Lei Yu
JYJingyun Yang
Jingyun Yang
DBDavid A. Bennett
David A. Bennett
JZJinying Zhao
Jinying Zhao
SWSamuel S. Wu
Samuel S. Wu